Invesaro

Stocks Health care BAX

NYSE · Health care

Baxter International Inc (BAX)

Baxter International Inc brought in $11.5B of revenue over the twelve months to June 30, 2026, up 5.4% from a year earlier. It posted a net loss of $1.1B. Operating cash flow minus capital spending left $332M of free cash flow in fiscal 2025. At June 30, 2026 it held $2.2B in cash against $844M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 30, 2026.

Price
$23.37
-0.47% on the day · September 25, 2026
52-week range $15.73 to $30.00
Market cap
$12.1B
Revenue (last 12 months)
$11.5B
+5.4% year on year
Net margin
-9.3%

What Baxter International Inc does

Baxter International Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker BAX.

Revenue and profit by year

Revenue
FY18: $11.1B $11.1B FY18FY19: $11.4B $11.4B FY19FY20: $11.7B $11.7B FY20FY21: $12.1B $12.1B FY21FY22: $10.1B $10.1B FY22FY23: $10.4B $10.4B FY23FY24: $10.6B $10.6B FY24FY25: $11.2B $11.2B FY25
Net income
FY18: $1.5B $1.5B FY18FY19: $1B $1B FY19FY20: $1.1B $1.1B FY20FY21: $1.3B $1.3B FY21FY22: -$2.4B -$2.4B FY22FY23: $2.7B $2.7B FY23FY24: -$649M -$649M FY24FY25: -$957M -$957M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$11.2B-$308M-$957M-$1.87$332M
2024$10.6B$14M-$649M-$1.27$573M
2023$10.4B$707M$2.7B$5.23$1.3B
2022$10.1B-$2.8B-$2.4B-$4.83$834M
2021$12.1B$1.4B$1.3B$2.53$1.5B
2020$11.7B$1.6B$1.1B$2.13$1.2B

Latest SEC filings

What Baxter International Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 19, 2026
  2. August 18, 2026
  3. August 4, 2026
  4. August 4, 2026
  5. July 30, 2026
    Quarterly report 10-Q · period to June 30, 2026
  6. July 30, 2026
  7. July 14, 2026
  8. June 5, 2026
  9. May 29, 2026
  10. May 8, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 18, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about BAX

What does Baxter International Inc do?

Baxter International Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker BAX.

Is Baxter International Inc profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $1.1B on revenue of $11.5B.

How much revenue does Baxter International Inc make?

Over the twelve months to June 30, 2026 Baxter International Inc reported revenue of $11.5B. That is 5.4% more than a year earlier.

When did Baxter International Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 30, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the new insider holdings from September 18, 2026.

Similar companies

Follow BAX

Get an email when Baxter International Inc files with the SEC: results, executive changes, material agreements and annual reports.

Follow BAX: get an email when it files

Where the numbers come from

Financial figures are the values Baxter International Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.